← SynDRA
NADOLOL
SynDRA canonical compound SYN0012026 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
| Indication | angina pectoris | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB1 ANTAGONIST
- ADRB2 ANTAGONIST
- ADRB3 ANTAGONIST
- ADRB1 MODULATOR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Antagonists
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympatholytics
ATC classes
- BETA BLOCKING AGENTS
- BETA BLOCKING AGENTS AND THIAZIDES
Cross-references
Synonyms
- CORGARD
- CORZIDE
- Corgard
- NADOLOL AND BENDROFLUMETHIAZIDE
- corgard
- anabet
- solgol
- NSC-758430
- SQ-11725
- Nadolol component of corzide
- Solgol
- Anabet
- Corgaretic
- Nadic
- Nadololum
- SQ11725
- Anabet (TN)
- Corgard (TN)
- Corzide (TN)
- Nadololum [INN-Latin]
- Solgol (TN)
- Alti-Nadolol (TN)
- Apo-Nadol (TN)
- Novo-Nadolol (TN)
- Nadolol (JP15/USP/INN)
- Nadolol [USAN:BAN:INN:JAN]
- Corgard;Solgol
- SMR000304369
- rac-Nadolol
- Nadolol (Standard)
- Corzide (Salt/Mix)
- Prestwick3_000818
- Oprea1_423217
- BSPBio_000715
- MLS001333998
- MLS001333999
- MLS002154017
Look up NADOLOL in the interactive SynDRA portal →